|
Volumn 365, Issue 9473, 2005, Pages 1766-1767
|
New-onset diabetes after transplantation [3] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ATORVASTATIN;
CYCLOSPORIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PRAVASTATIN;
SIMVASTATIN;
TACROLIMUS;
IMMUNOSUPPRESSIVE AGENT;
BONE GRAFT;
CLINICAL TRIAL;
DIABETES MELLITUS;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
INCIDENCE;
KIDNEY TRANSPLANTATION;
LETTER;
LIFESTYLE;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SURVIVAL RATE;
TRANSPLANTATION;
HEPATITIS C;
LIVER TRANSPLANTATION;
NOTE;
RISK FACTOR;
VIROLOGY;
DIABETES MELLITUS;
HEPATITIS C;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
RISK FACTORS;
|
EID: 19744375905
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)66574-9 Document Type: Letter |
Times cited : (3)
|
References (5)
|